Novartis Venture Fund

company

About

Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms.

  • 11 - 50

Details

Industries
Finance,Therapeutics,Venture Capital
Founded date
Jan 1, 1996
Number Of Employee
11 - 50
Operating Status
Active
Investor Type
CVC,Venture Capital

Our primary focus is on the development of novel therapeutics and platforms. We balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capital efficiency in the program.

We prefer to have our initial investment at the early stage to build the company and follow with additional investment in pace with the company:tm:s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 30 to 50 mio per company over its life, but it can be as little as 100'000 USD to get started. We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates.

Sectors

New therapeutics & platforms
Medical devices/implants
Diagnostics/biomarkers
Drug delivery/biopolymers
Geography

USA/Canada
Europe
Switzerland
Asia/Pacific

Investments

Number of Investments
Number of Lead Investments
10
4
Novartis Venture Fund has made 10 investments. Their most recent investment was on Nov 22, 2022, when CatalYm raised €50M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 22, 2022 CatalYm
Series C €50M Biotechnology
Series B ¥100M Artificial Intelligence Yes
Series B $53M Biopharma
Nov 19, 2020 CatalYm
Series B €50M Biotechnology
Sep 2, 2019 Adicet Bio
Series B $80M Biopharma